|4Apr 4, 4:46 PM ET

Cidara Therapeutics, Inc. 4

4 · Cidara Therapeutics, Inc. · Filed Apr 4, 2017

Insider Transaction Report

Form 4
Period: 2017-03-31
Bartizal Ken
Chief Development Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2017-03-31+50,00050,000 total
    Exercise: $7.80Exp: 2027-03-30Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 31, 2017.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION